The report titled “Gastrointestinal Bleeding Treatment Market” report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners, and industry experts.
Gastrointestinal Bleeding refers to blood loss that occurs within the digestive organs. High prevalence of upper gastrointestinal bleeding, rise in applications of endoscopic hemostasis, and growing geriatric population are the main factors that are boosting the growth of the gastrointestinal bleeding treatment market. According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world’s population over 60 years will nearly double from 12% to 22%.
The increase in the number of geriatrics leads to consequences, such as a greater incidence of life-threatening diseases which sometimes related to gastrointestinal bleeding, further requiring treatment from hospitals. This boost the growth of the studied market.
Click the link to get a Sample Copy:
Key Market Trends
Upper GI Tract Segment is Expected to Register a Good Growth Over the Forecast Period
By GI tract division, the market has been segmented into Upper GI Tract, and Lower GI Tract. The upper GI tract accounted for major share in the gastrointestinal bleeding treatment market and this trend is likely to continue during the forecast period. A peptic ulcer is one of the most common causes of upper GI tract bleeding and is known to have increased prevalence owing to an increase in H. pylori infection.
Regional Analysis For Gastrointestinal Bleeding Treatment Market:
For the comprehensive understanding of market dynamics, the global Gastrointestinal Bleeding Treatment Market is analyzed across key geographies namely: United States, China, Europe, Japan, South-east Asia, India, and others. Each of these regions is analyzed based on market findings across major countries in these regions for a macro-level understanding of the market.
North America leads the market owing to the upsurge in the demand for advanced treatment options, and the prevalence of upper gastrointestinal bleeding. According to The National Institute of Diabetes and Digestive and Kidney Diseases, every year, upper GI bleeding accounts for about 100,000 hospitalizations in the United States. There is a large section of the population in the adult age group across many states, which have unhealthy diet habits leading to several problems associated to the upper and lower gastrointestinal tract, which may lead to bleeding if not diagnosed properly. Thus, a growing burden of such patients are being observed approaching the hospitals for better treatment particularly during the advanced stage of the disease. This drives the market of the gastrointestinal bleeding treatment
Browse the report description and TOC:
The major players in the gastrointestinal bleeding treatment market include Boston Scientific Corporation, CONMED Corporation, Cook Group, ERBE Elektromedizin GmbH, Olympus Corporation, Ovesco Endoscopy AG, STERIS PLC and US Medical Innovations are providing these products across the globe.
Please connect with our sales team ([email protected]).
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687